Norristown, PA, United States of America

Kimberly A Kraynyak

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovator in Cancer Treatment: Kimberly A. Kraynyak**

Introduction

Kimberly A. Kraynyak, based in Norristown, PA, is a prominent inventor with a patent focused on an innovative approach to treating brain cancer. With her expertise and dedication, she has contributed significantly to the medical field, particularly in developing methods that utilize advanced biological research.

Latest Patents

Kraynyak holds a patent for a combination therapy aimed at treating brain cancer. The patent details methods that involve evaluating biological samples for specific microRNAs (miRNAs) and administering a combination of interleukin-12 (IL-12), an immunogenic composition of human telomerase reverse transcriptase (hTERT), Wilms Tumor-1 (WT-1), prostate-specific membrane antigen (PSMA), and an anti-programmed cell death receptor 1 (PD-1) antibody. This innovative approach aims to tailor treatment based on the expression levels of particular miRNAs and mRNA biomarkers found in tumor samples, demonstrating a sophisticated understanding of cancer biology.

Career Highlights

Kraynyak has collaborated with several esteemed organizations throughout her career, enhancing her expertise in the biopharmaceutical sector. Notably, she has worked for Inovio Pharmaceuticals and Regeneron Pharmaceuticals, where she contributed to advancing cancer therapies and deepening her knowledge of therapeutic development.

Collaborations

During her professional journey, Kraynyak has partnered with distinguished colleagues, including Amy-Lee Bredlau and Israel Lowy. These collaborations have facilitated the exchange of ideas and fostered innovation in the field of oncology, further underpinning the importance of teamwork in advancing medical research.

Conclusion

Kimberly A. Kraynyak's contributions to brain cancer treatment exemplify the impact of innovative thinking in the medical field. Her patent illustrates a commitment to enhancing patient outcomes through targeted therapies. As she continues to work alongside industry leaders, her work is likely to influence cancer treatment methodologies for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…